Feeling awful on TRT: what the science says about why
Quick answer
After approximately five months of testosterone therapy, this individual stopped abruptly and presents with a total testosterone of 190 ng/dL at roughly two to three weeks post-cessation, consistent with HPG axis suppression and delayed endogenous recovery. The reported symptoms of fatigue and lightheadedness are clinically consistent with hypogonadal state. The mention of a planned therapeutic phlebotomy before restarting suggests elevated hematocrit, a documented adverse effect of testosterone therapy requiring monitoring.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @baughhh actually say?
After stopping testosterone for two to three weeks, this creator got bloodwork showing a level of 190 ng/dL, down from 1,400 ng/dL while on TRT. He describes feeling exhausted, lightheaded, and generally awful. His conclusion: "don't get off of it" unless you're having serious problems, and he plans to do a "blood dump" before restarting.
That's a real, relatable experience. It's also missing some important context about why this happens, how long it lasts, and what "blood dump" actually means in clinical terms. The feelings he describes are real. The blanket advice to never stop is where things get more complicated.
Does the science back this up?
Yes, mostly. When you stop exogenous testosterone after months of use, your endogenous production doesn't snap back immediately. The hypothalamic-pituitary-gonadal axis, which got suppressed during TRT, takes time to recover. A level of 190 ng/dL two to three weeks after stopping is consistent with what the literature documents.
A 2020 study by Ramasamy et al. in the Journal of Urology found that recovery of natural testosterone production after stopping TRT can take anywhere from three months to over a year, depending on duration of use, age, and baseline function. Men with pre-existing hypogonadism may never fully recover without intervention. Baughhh was on TRT for roughly five months, which is long enough to significantly suppress the HPG axis but probably not long enough to cause permanent suppression in a younger, otherwise healthy individual.
The fatigue and lightheadedness he describes are well-documented symptoms of low testosterone. Studies consistently show that men with total testosterone below 300 ng/dL report significant quality-of-life impairment, including fatigue, mood changes, and reduced physical performance (Zitzmann, 2009, European Journal of Endocrinology).
What did they get wrong (or right)?
He got the core physiology right: stopping TRT causes a temporary crash. Credit where it's due. But the advice to "don't get off of it" is an oversimplification that could actually cause harm if taken at face value.
Here's what's missing. First, why someone goes on TRT matters enormously. If your pre-TRT levels were already low, stopping cold turkey without a proper taper or recovery protocol, like a SERM-based restart, is going to feel terrible and may delay recovery. That's not a reason to stay on forever. That's a reason to come off properly.
Second, his "blood dump" comment deserves some unpacking. This likely refers to a therapeutic phlebotomy, a standard procedure to lower elevated hematocrit, a known side effect of testosterone therapy. This is a legitimate clinical concern. Polycythemia from TRT increases clotting risk, and managing it before restarting is actually responsible. He doesn't explain this to his audience, though, and just calling it a "blood dump" leaves a lot of people confused.
He also doesn't mention that a 1,400 ng/dL level on TRT is well above the typical therapeutic target range of 400 to 700 ng/dL cited in most endocrinology guidelines. That's not necessarily alarming on its own, but it's relevant context.
What should you actually know?
If you're on TRT and considering stopping, the crash this creator experienced is real and predictable. Your body's natural testosterone production gets suppressed during exogenous use. When you stop abruptly, especially without a medically supervised recovery protocol, you're going to feel it.
This does not mean you should stay on TRT indefinitely to avoid discomfort. That's circular logic. What it means is that stopping should be planned with a healthcare provider. Post-cycle recovery protocols using medications like clomiphene or tamoxifen, which stimulate the HPG axis, have clinical evidence behind them and can significantly shorten recovery time (Shabsigh et al., 2005, Journal of Sexual Medicine).
Also worth knowing: if your levels were already low before starting TRT (below 300 ng/dL on two morning tests, the standard diagnostic threshold), then stopping may simply return you to your baseline. In that case, the question isn't "should I come off" but rather "what's the right long-term management plan." That's a conversation for a physician, not a TikTok comment section.
Blanket statements like "don't get off of it" flatten a genuinely complex decision. For some men, long-term TRT is the right call. For others, addressing root causes like sleep apnea, obesity, or medication side effects can restore function. Nobody should make that call based on one person's worst two weeks.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Feeling awful on TRT: what the science says about why, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Feeling awful on TRT: what the science says about why is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
After approximately five months of testosterone therapy, this individual stopped abruptly and presents with a total testosterone of 190 ng/dL at roughly two to three weeks post-cessation, consistent with HPG axis suppression and delayed endogenous recovery.
FormBlends verdict
After approximately five months of testosterone therapy, this individual stopped abruptly and presents with a total testosterone of 190 ng/dL at roughly two to three weeks post-cessation, consistent with HPG axis suppression and delayed endogenous recovery. The reported symptoms of fatigue and lightheadedness are clinically consistent with hypogonadal state. The mention of a planned therapeutic phlebotomy before restarting suggests elevated hematocrit, a documented adverse effect of testosterone therapy requiring monitoring.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- After approximately five months of testosterone therapy, this individual stopped abruptly and presents with a total testosterone of 190 ng/dL at roughly two to three weeks post-cessation, consistent with HPG axis suppression and delayed endogenous recovery. The reported symptoms of fatigue and lightheadedness are clinically consistent with hypogonadal state. The mention of a planned therapeutic phlebotomy before restarting suggests elevated hematocrit, a documented adverse effect of testosterone therapy requiring monitoring.
- Testosterone levels can drop sharply after stopping TRT, with a 2020 Ramasamy et al. study in the Journal of Urology showing HPG axis recovery can take three months to over a year depending on age and duration of use.
- A total testosterone of 190 ng/dL falls well below the 300 ng/dL clinical threshold for symptomatic hypogonadism, making the reported fatigue and lightheadedness physiologically expected.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone levels can drop sharply after stopping TRT, with a 2020 Ramasamy et al. study in the Journal of Urology showing HPG axis recovery can take three months to over a year depending on age and duration of use.
- A total testosterone of 190 ng/dL falls well below the 300 ng/dL clinical threshold for symptomatic hypogonadism, making the reported fatigue and lightheadedness physiologically expected.
- 1,400 ng/dL on TRT is above the typical therapeutic target range of 400 to 700 ng/dL used in most endocrinology guidelines, which is worth discussing with a prescribing provider.
- Stopping TRT abruptly without a recovery protocol is not the only option. SERM-based restarts using medications like clomiphene have clinical support for stimulating natural production (Shabsigh et al., 2005, Journal of Sexual Medicine).
- Elevated hematocrit is a documented side effect of testosterone therapy. Therapeutic phlebotomy before restarting, as this creator describes, is a legitimate clinical management step.
- Blanket advice to never stop TRT ignores that some patients have treatable underlying causes of low testosterone, including obesity, sleep apnea, or medication effects, where addressing the root cause may restore levels.
- Any decision to start, stop, or restart testosterone therapy should involve a licensed provider reviewing current labs, symptoms, and individual health history.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jeramy Baugh · TikTok creator
62.2K views on this video
I feel like crap #trt #gym #testosterone #fyp
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Jeramy Baugh, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.